Mersana Therapeutics Other Long Term Liabilities (Quarterly) Insights

Mersana Therapeutics, Inc. (MRSN)

29.08 0.00 (0.00%) USD | NASDAQ | Jan 13, 16:00

View Other Long Term Liabilities (Quarterly) for MRSN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Cidara Therapeutics, Inc.	--
Day One Biopharmaceuticals, Inc.	Upgrade
Semler Scientific, Inc.	--
Cue Biopharma, Inc.	--
Scholar Rock Holding Corp.	--